| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From the Department of Medicine (J.H.T., Y.C., M.H., Y.L., R.J.B.), Division of Cardiology, University of Minnesota Medical School and the Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital (J.H.T.), Minneapolis, Minn.
Correspondence Jay H Traverse, MD, Division of Cardiology, University of Minnesota, MMC 508 UMHC, 420 Delaware Street SE, Minneapolis, MN 55455. E-mail trave004{at}umn.edu
K+ATP channels are important metabolic regulators of coronary blood flow (CBF) that are activated in the setting of reduced levels of ATP or perfusion pressure. In the normal heart, blockade of K+ATP channels results in a
20% reduction in resting CBF but does not impair the increase in CBF that occurs during exercise. In contrast, adenosine receptor blockade fails to alter CBF or myocardial oxygen consumption (MVO2) in the normal heart but contributes to the increase in CBF during exercise when vascular K+ATP channels are blocked. Congestive heart failure (CHF) is associated with a decrease in CBF that is matched to a decrease in MVO2 suggesting downregulation of myocardial energy utilization. Because myocardial ATP levels and coronary perfusion pressure are reduced in CHF, this study was undertaken to examine the role of K+ATP channels and adenosine in dogs with pacing-induced CHF. Myocardial blood flow (MBF) and MVO2 were measured during rest and treadmill exercise before and after K+ATP channel blockade with glibenclamide (50 µg/kg/min ic) or adenosine receptor blockade with 8-phenyltheophylline (8-PT; 5 mg/kg iv). Inhibition of K+ATP channels resulted in a decrease in CBF and MVO2 at rest and during exercise without a change in the relationship between CBF and MVO2. In contrast, adenosine receptor blockade caused a significant increase in CBF that occurred secondary to an increase of MVO2. These findings demonstrate that coronary K+ATP channel activity contribute to the regulation of resting MBF in CHF, and that endogenous adenosine may act to inhibit MVO2 in the failing heart.
Key Words: heart failure K+ATP channels coronary blood flow exercise myocardial oxygen consumption
This article has been cited by other articles:
![]() |
X. Xu, J. Fassett, X. Hu, G. Zhu, Z. Lu, Y. Li, J. Schnermann, R. J. Bache, and Y. Chen Ecto-5'-Nucleotidase Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction Hypertension, June 1, 2008; 51(6): 1557 - 1564. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |